Plain-English translation of NCT06287398 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new drug called as part of a multi-step treatment plan for people whose large B-cell lymphoma has returned or stopped responding to their first round of treatment. The study combines with intensive chemotherapy, then moves to a stem cell transplant, and finishes with more of the medication to try to prevent the cancer from coming back. Researchers want to know if this combination approach is safe and works better than current standard treatments.
Large B-cell lymphoma that comes back after initial treatment is very difficult to treat, and doctors need new options to help patients achieve better long-term remission. This trial is exploring whether adding this new medication to the transplant process can improve survival and reduce the chance of cancer recurrence.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would go through three main phases over several months. First, you would receive 3 cycles of combination chemotherapy plus the new medication (each cycle lasts about 3–4 weeks). If this works well, you would then undergo a stem cell transplant at your local cancer center. Finally, about 2–3 months after the transplant, you would receive 6 more months of the medication given as injections under the skin. Throughout the trial, you would have regular blood tests, scans, and clinic visits to monitor your response and watch for side effects.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Australia